Rep. Maria Elvira Salazar Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Posted by Jessica Moore on May 12th, 2026

Representative Maria Elvira Salazar (Republican-Florida) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on April 22nd. The trade occurred in the Representative’s “UBS BROKERAGE ACCOUNT” account.

Representative Maria Elvira Salazar also recently made the following trade(s):

Purchased $15,001 – $50,000 in shares of Carrier Global (NYSE:CARR) on 5/1/2026.
Purchased $1,001 – $15,000 in shares of Carrier Global (NYSE:CARR) on 5/1/2026.
Purchased $1,001 – $15,000 in shares of United Rentals (NYSE:URI) on 4/24/2026.
Purchased $1,001 – $15,000 in shares of Sherwin-Williams (NYSE:SHW) on 4/20/2026.
Purchased $15,001 – $50,000 in shares of Sherwin-Williams (NYSE:SHW) on 4/20/2026.
Purchased $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 4/17/2026.
Sold $15,001 – $50,000 in shares of Amgen (NASDAQ:AMGN) on 4/17/2026.
Purchased $1,001 – $15,000 in shares of Voyager Technologies (NYSE:VOYG) on 4/14/2026.
Purchased $15,001 – $50,000 in shares of Marvell Technology (NASDAQ:MRVL) on 4/6/2026.
Purchased $15,001 – $50,000 in shares of Salesforce (NYSE:CRM) on 4/6/2026.

UnitedHealth Group Trading Up 2.1%

Shares of UNH traded up $8.26 during mid-day trading on Tuesday, reaching $392.70. 4,836,887 shares of the company were exchanged, compared to its average volume of 9,292,583. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $394.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80. The stock has a market capitalization of $356.62 billion, a PE ratio of 29.65, a PEG ratio of 1.64 and a beta of 0.64. The business has a 50 day simple moving average of $308.40 and a two-hundred day simple moving average of $317.22.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm’s revenue was up 2.0% compared to the same quarter last year. During the same period last year, the company earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 66.77%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Optum Rx announced an industry-first transparent PBM model that replaces volume-linked pricing with a fee-based structure, which may reduce regulatory pressure and improve customer trust. Optum Rx Introduces Industry’s First Transparent Pharmacy Care Model
Positive Sentiment: The new Optum Rx model includes digital tools that show prescription-level cost estimates, which could support better pricing transparency and strengthen UnitedHealth’s competitive positioning in pharmacy benefits. Will UnitedHealth’s New Optum Rx Model Boost PBM Pricing Transparency?
Neutral Sentiment: UnitedHealth remains a focus of analyst research coverage, with commentary pointing to its growth drivers and earnings profile rather than any new fundamental shock. The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
Neutral Sentiment: Additional Zacks coverage also highlighted UNH among top research picks, reinforcing ongoing investor interest in the stock’s longer-term fundamentals. Top Research Reports for UnitedHealth, Merck & Qualcomm
Neutral Sentiment: A separate note repeated the Optum Rx pricing shift story, underscoring that the market’s main catalyst today is the new PBM transparency initiative. Optum Rx Pricing Shift Puts New Focus On UnitedHealth Group Valuation

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $389.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target on the stock in a research note on Wednesday, April 22nd. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a research note on Tuesday, April 7th. Finally, Raymond James Financial upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price objective for the company in a report on Wednesday, April 1st. One analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $378.88.

Get Our Latest Stock Analysis on UNH

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently modified their holdings of the company. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at $340,000. Flow Traders U.S. LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at $356,000. Finally, Jump Financial LLC purchased a new position in shares of UnitedHealth Group during the 2nd quarter valued at $377,000. Institutional investors own 87.86% of the company’s stock.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.

Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.